Initial 6-month quality review of a percutaneous endovascular arteriovenous fistula program.

Arteriovenous fistula Ellipsys WavelinQ dialysis dialysis access endovascular arteriovenous fistula hemodialysis percutaneous arteriovenous fistula percutaneous endovascular arteriovenous fistula

Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 21 8 2020
medline: 18 11 2021
entrez: 21 8 2020
Statut: ppublish

Résumé

Percutaneous arteriovenous fistulas have recently proven successful alternatives to surgical arteriovenous fistulas with encouraging initial results. The We performed a retrospective chart review of the initial 6 months (January 1 Initial technical success was achieved in 17 out of 18 arteriovenous fistulas (94.4%). Three patients did not report for any follow-up at the end of the initial 6 months. Of the remaining patients, 7 out of 15 were using their arteriovenous fistulas or meeting maturation characteristics at the end of the study (46.7%). Patient loss to follow-up/no-show (16.7%), patient not yet requiring hemodialysis (27.8%), and poor post-surgical maturation and/or need for additional maturation procedures (55.6%) were the predominate reasons for non-use. We identified improved coordination of care, early intervention, and outpatient dialysis center education as the primary areas of focus for quality improvement. Initial technical success rate of percutaneous arteriovenous fistulas placement was comparable to published studies. Early and aggressive secondary angiographic interventions of arteriovenous fistulas failing to meet cannulation requirements, improved coordination of post-operative care, and outpatient dialysis center education appear to be the primary targets for quality improvement.

Sections du résumé

BACKGROUND BACKGROUND
Percutaneous arteriovenous fistulas have recently proven successful alternatives to surgical arteriovenous fistulas with encouraging initial results. The
METHODS METHODS
We performed a retrospective chart review of the initial 6 months (January 1
RESULTS RESULTS
Initial technical success was achieved in 17 out of 18 arteriovenous fistulas (94.4%). Three patients did not report for any follow-up at the end of the initial 6 months. Of the remaining patients, 7 out of 15 were using their arteriovenous fistulas or meeting maturation characteristics at the end of the study (46.7%). Patient loss to follow-up/no-show (16.7%), patient not yet requiring hemodialysis (27.8%), and poor post-surgical maturation and/or need for additional maturation procedures (55.6%) were the predominate reasons for non-use. We identified improved coordination of care, early intervention, and outpatient dialysis center education as the primary areas of focus for quality improvement.
CONCLUSION CONCLUSIONS
Initial technical success rate of percutaneous arteriovenous fistulas placement was comparable to published studies. Early and aggressive secondary angiographic interventions of arteriovenous fistulas failing to meet cannulation requirements, improved coordination of post-operative care, and outpatient dialysis center education appear to be the primary targets for quality improvement.

Identifiants

pubmed: 32815463
doi: 10.1177/1129729820948692
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

540-546

Auteurs

Sulaiman Sultan (S)

Division of Nephrology, The University of New Mexico, Albuquerque, NM, USA.

Mark Langsfeld (M)

Division of Vascular Surgery, The University of New Mexico, Albuquerque, NM, USA.

LeAnn Chavez (L)

Division of Vascular Surgery, The University of New Mexico, Albuquerque, NM, USA.

Anna Fabre (A)

Division of Interventional Radiology, The University of New Mexico, Albuquerque, NM, USA.

Robin Osofsky (R)

Division of Vascular Surgery, The University of New Mexico, Albuquerque, NM, USA.

Christos Argyropoulos (C)

Division of Nephrology, The University of New Mexico, Albuquerque, NM, USA.

Jonathan G Owen (JG)

Division of Nephrology, The University of New Mexico, Albuquerque, NM, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH